Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist for type 2 diabetes and weight management, which works by suppressing appetite, slowing gastric emptying, increasing feelings of fullness, and reducing calorie intake
It may be that taking GLP-1 drugs for weight loss is an effective intervention for some employees that will improve health outcomes and reduce costs
10.3390/antiox10091455 54 GongL.YuL.GongX.WangC.HuN.DaiX.et al (2020)
This is your daily investment in mental clarity, motivation, and long-term cognitive resilience
Data availability Data associated with this article can be found within the article or in the corresponding supplemental materials
When HGH levels increase, it creates a wide range of anti-aging benefits